Finally, in the last paper, X. Meng and colleagues test whether synthetic lethality can be achieved in endometrial cancer cells expressing mutant p53 by combining paclitaxel with agents to overcome G2/M arrest thereby inducing mitotic catastrophe. The gene discussed is TP53; the disease is endometrial cancer.